Cord Blood Transplantation for Children and Young Adults with Blood Cancer

Sponsor: Memorial Sloan Kettering Cancer Center

Sponsor score: 60

ClinicalTrials ID:NCT07566377

This study is exploring whether using cord blood for transplantation can be an effective treatment for children and young adults with blood cancer, either as their first or second transplant.

Patient Parameters

Program Overview

The aim of this study is to determine if cord blood transplantation (CBT) is a successful treatment option for children and young adults with blood cancer. The study will evaluate the effectiveness of CBT when used as the first or second transplant in these patients.

Eligibility Criteria

Inclusion Criteria

  • Children and young adults aged 0-26 years with specific types of blood cancer.
  • No suitable matched donor available within 4 weeks.
  • Diagnosed with high-risk blood cancers like acute myelogenous leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), or certain types of lymphoma.
  • Cancer must be in remission or have specific high-risk features.
  • Must have good organ function and overall health.
  • Not pregnant or nursing.
  • Willing to use effective birth control if of childbearing potential.
  • Meet specific blood and organ function criteria, such as liver and kidney function tests.
  • Must have a performance score indicating good physical health.
  • Provide informed consent to participate in the study.

Exclusion Criteria

  • Poor overall health or organ function.
  • Active leukemia in the central nervous system.
  • Large chloroma (a type of tumor) over 2 cm.
  • Active and uncontrolled infections.
  • HIV or HTLV-1 infection.
  • Pregnant or breastfeeding.
  • Unable to provide informed consent or follow the study protocol.
  • Recent allogeneic transplant within the last 4 months for very high-risk patients.
  • Active hepatitis B or C infection unless under control or treated.
  • Recent use of certain immune therapies may require discussion with the study lead.

Locations

FACILITYZIPCITYSTATE
Memorial Sloan Kettering Cancer Center (All Protocol Activities)10065New YorkNew York

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.